|
Market Closed -
Nasdaq
20:30:00 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 4.030 USD | +7.47% |
|
+6.33% | -82.00% |
Evolution of the Average Target: Revelation Biosciences, Inc.
Evolution of the Target Price: Revelation Biosciences, Inc.
Changes in Analyst Recommendations: Revelation Biosciences, Inc.
3e8edd3f73b.quEebW_oAu2ywNXjeCEvaCbIEu9BgOD-lRoHfTv9aJc.-9dLVASBbtvIt4bbEkseUX-GQZ8KwY-28UVlF1GUC9-b2VVeBI5bv9Tz5Q~e0b34add31ee6ad97d8a19c21a294662
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | +2,983.13% | ||||
| +42.48% | |||||
| +24.46% | |||||
| +8.41% | |||||
| +15.87% | |||||
| +17.86% | |||||
| +35.3% | |||||
| +1.94% | |||||
| +41.27% | |||||
| +72.28% | |||||
| Average | +324.30% | |||||
| Weighted average by Cap. | +27.03% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.030USD
Average target price
124.25USD
Spread / Average Target
+2,983.13%
High Price Target
136.50USD
Spread / Highest target
+3,287.10%
Low Price Target
112.00USD
Spread / Lowest Target
+2,679.16%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- REVB Stock
- Consensus Revelation Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
